Sign In
Buy VCYT
$56.97
-2.33 (-3.93%)
At Close: Jul 10, 2026
Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer
08:15am, Tuesday, 22'nd Dec 2020
WHIPPANY, N.J. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Bayer and Veracyte (Nasdaq:VCYT) today announced a new collaboration to advance the Precision Oncology Patient Identification Program in
Veracyte: A Strong Recovery Turning Into Strong Growth In The Midst Of A Pandemic
10:18pm, Monday, 21'st Dec 2020
Veracyte: A Strong Recovery Turning Into Strong Growth In The Midst Of A Pandemic
Veracyte to Host Virtual Lung Cancer R&D Day on Wednesday, December 16, 2020
02:30pm, Thursday, 03'rd Dec 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte to Host Virtual Lung Cancer R&D Day on Wednesday, December 16, 2020
Veracyte, Inc. (VCYT) CEO Bonnie Anderson on Q3 2020 Results - Earnings Call Transcript
11:33pm, Monday, 02'nd Nov 2020
Veracyte, Inc. (VCYT) CEO Bonnie Anderson on Q3 2020 Results - Earnings Call Transcript
Veracyte (VCYT) Reports Q3 Loss, Tops Revenue Estimates
06:55pm, Monday, 02'nd Nov 2020
Veracyte (VCYT) delivered earnings and revenue surprises of 55.56% and 25.24%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
